Status:

UNKNOWN

Program Evaluation of Telehomecare: TeLeCare Study

Lead Sponsor:

University of Toronto

Collaborating Sponsors:

Ontario Ministry of Health and Long Term Care

Conditions:

Heart Failure

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

18+ years

Brief Summary

This study will evaluate the Telehomecare (THC) Program offered to patients with heart failure or chronic obstructive pulmonary disease across the Central West, Toronto Central and North East Local He...

Detailed Description

The program evaluation will consist of three components that will employ two research methods, qualitative and quantitative. Comparative Practice Study (Qualitative) This study will explore how facto...

Eligibility Criteria

Inclusion

  • Patient
  • The patient has a documented diagnosis of HF or COPD (with or without co-morbid conditions)
  • The patient is a 'heavy user' of the health care system, characterized by any of the following:
  • A minimum of one hospitalization for a respiratory or cardiac complaint in the past six months
  • A minimum of two emergency department/urgent care center visits for a respiratory or cardiac complaint in the past six months
  • Is receiving nursing services via CCAC
  • Frequent visits to primary care provider in the past year
  • The patient or informal caregiver (if applicable) is an adult (over 18 yrs) able and willing to provide informed consent.
  • The patient or informal caregiver (if applicable) is fluent in English
  • The patient or informal caregiver is able and willing to operate the THC equipment
  • The patient lives in a residential (private home or retirement home) setting with an active landline
  • The patient or informal caregiver have agreed to be contacted for evaluation of this program when consenting to participate in the Telehomecare program.
  • Health Care Provider
  • Any health care provider who referred a patient to the telehomecare program
  • Primary care providers of patients who are enrolled in the study
  • Telehomecare nurses/physicians involved in the provision of care to patients enrolled in the telehomecare program
  • For interviews and surveys telehomecare nurses/physicians must have 3 months experience with telehomecare
  • Technician, Administrators and/or Decision Makers
  • Technicians involved in the set-up of telehomecare equipment at patients' homes.
  • Administrators and/or Decision Makers of the THC program as a larger network of care such as Healthcare Program Managers, key members of the LHIN, OTN etc.

Exclusion

  • Patient
  • Less than 18 years of age
  • Individuals without an established diagnosis of COPD or chronic HF
  • Unable or unwilling to provide verbal informed consent
  • Demonstrated non-adherence to the THC program
  • The THC Clinician works with each patient on a case-by-case review to assess willingness to partner in their own care, and if the number of missed consultation appointments and reasons for demonstrate overall non-adherence with the program.
  • Inability or unwillingness to use THC equipment
  • Do not have a regular caregiver to assist in the use of the equipment
  • Health Care Provider, Technician, Administrators and/or Decision Makers
  • \- Unable or unwilling to provide verbal informed consent

Key Trial Info

Start Date :

June 1 2014

Trial Type :

OBSERVATIONAL

End Date :

September 1 2018

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT02311114

Start Date

June 1 2014

End Date

September 1 2018

Last Update

March 22 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Toronto

Toronto, Canada

Program Evaluation of Telehomecare: TeLeCare Study | DecenTrialz